# Cellectar Biosciences, Inc.: Form 10-K/A for the period ended Dec 31, 2022

- Company: [Cellectar Biosciences, Inc.](/companies/clrb.md) (CIK 1279704)
- Form: 10-K/A
- Filed: 2023-03-16
- Accepted by EDGAR: Mar 16, 2023, 16:36 ET
- Period: 2022-12-31
- Accession: 0001104659-23-033350
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1279704/000110465923033350/tm239725d1_10ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1279704/000110465923033350/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1279704/000110465923033350/tm239725d1_10ka.htm

Filed Mar 16, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-033350. Last ingested by Listed: Nov 10, 2026, 16:55 ET. No prices; not investment advice.
